Chines A, Petersen D J, Schranck F W, Whyte M P
Metabolic Research Unit, Shriners Hospital for Crippled Children, St. Louis, MO 63131.
J Pediatr. 1991 Jul;119(1 Pt 1):51-7. doi: 10.1016/s0022-3476(05)81038-8.
To investigate our impression that hypercalciuria is relatively common in children with osteogenesis imperfecta, we performed a retrospective study of data accumulated from our pediatric population with this skeletal disorder. Children with osteogenesis imperfecta (17 girls, 30 boys; mean (+/- SD) age 7.8 +/- 4.6 years; range 0.7 to 16.8 years) had undergone detailed inpatient evaluation of mineral homeostasis during periods of clinical stability and controlled dietary calcium intake. Hypercalciuria was found in 36% of the patients and averaged (+/- SEM) 6.1 +/- 0.3 mg/kg per 24 hours (0.15 +/- 0.01 mmol/kg per 24 hours) or 392 +/- 28 mg/gm of creatinine (1.10 +/- 0.07 mmol calcium/mmol creatinine) in the group with hypercalciuria. There were no statistically significant differences in age, gender, or dietary calcium intake (per kilogram of body weight) between the normocalciuric and hypercalciuric children. However, the group with hypercalciuria was shorter than the normocalciuric group and had a greater lifelong fracture rate. When patient height z scores were regressed against urinary calcium levels, a significant negative correlation was found in the group with hypercalciuria (r = -0.76; p less than 0.001). Although serum alkaline phosphatase activity was lower in the group with hypercalciuria, no difference was found between groups with regard to serum levels of calcium, phosphate, magnesium, creatinine, immunoreactive parathyroid hormone, or osteocalcin. The groups were also similar with respect to both their total body mineral density, as determined by dual-photon absorptiometry (n = 17), and their static indexes of bone formation and resorption, as assessed histomorphometrically with iliac crest specimens (n = 19). We conclude that hypercalciuria occurs frequently in children with osteogenesis imperfecta, and that its magnitude appears to reflect the severity of the skeletal disease.
为了验证我们关于高钙尿症在成骨不全患儿中相对常见的印象,我们对患有这种骨骼疾病的儿科人群积累的数据进行了一项回顾性研究。成骨不全患儿(17名女孩,30名男孩;平均(±标准差)年龄7.8±4.6岁;范围0.7至16.8岁)在临床稳定期和控制饮食钙摄入量期间接受了详细的住院矿物质稳态评估。36%的患者发现有高钙尿症,高钙尿症组平均(±标准误)每24小时为6.1±0.3mg/kg(每24小时0.15±0.01mmol/kg)或每克肌酐392±28mg(1.10±0.07mmol钙/mmol肌酐)。正常钙尿症患儿和高钙尿症患儿在年龄、性别或饮食钙摄入量(每公斤体重)方面没有统计学上的显著差异。然而,高钙尿症组比正常钙尿症组更矮,终身骨折率更高。当将患者身高z评分与尿钙水平进行回归分析时,在高钙尿症组中发现了显著的负相关(r = -0.76;p < 0.001)。虽然高钙尿症组的血清碱性磷酸酶活性较低,但两组在血清钙、磷、镁、肌酐、免疫反应性甲状旁腺激素或骨钙素水平方面没有差异。通过双能光子吸收法测定(n = 17),两组的全身矿物质密度以及通过髂嵴标本组织形态计量学评估的骨形成和骨吸收静态指标也相似。我们得出结论,高钙尿症在成骨不全患儿中经常发生,其程度似乎反映了骨骼疾病的严重程度。